Catalyst Wire Dossier Catalyst Wire Dossier

Volixibat

volixibat · Mirum Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Volixibat, covering 2019-11-25 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis [Phase 2]

See pricing